Modulation of intracellular signal pathway for preventing liver damage after extended hepatectomy
Modulation of intracellular signal pathway for preventing liver damage after extended hepatectomy
批准号:
18591497
负责人:
UCHINAMI Hiroshi
金额:
$2.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Ischemia-reperfusion (I/R) injury of the liver is one of major problems after extended hepatectomy or liver transplantation. To perform operation much safer, some strategies to prevent I/R injury has been required.Nrf2 is a transcription factor that protects cell and tissues from oxidative stress by activating protective antioxidant and detoxifying enzymes. It is likely that preoperative activation of Nrf2 in liver-consisting cells results in prevention of I/R injury of the liver. In this protocol, we evaluated whether Nrf2 activation confer the tolerance for I/R injury of the liver.Oltipraz, 15-deoxy-Δ 12, 14-prostagrandine J2 (PGJ2), and diallyl sulfide (DAS) were used to confirm whether these drugs activate Nrf2 in liver-consisting cells. Liver epithelial cells and liver stellate cells were isolated from rat and mouse liver and cultured. Immunofluorescent assay revealed that Nrf-2 translocated into the nucleus immediately after stimulating by these drugs in both types of cells. The expression of HO-1 was also induced by PGJ2 in a dose dependent manner.It has been reported that activation of stellate cells has detrimental effect during hepatic I/R. To evaluate the effect of PGJ2 on stellate cell activation, the mRNA expression of alpha smooth muscle actin and type I collagen was examined by real time PCR. PGJ2 significantly inhibited the expression of both genes, suggesting that PGJ2 effectively suppressed the activation of stellate cells.Finally, the effect of PGJ2 on I/R injury was examined. C57/B16 mouse was used. We applied 70% ischemia model (60 min). PGJ2 was administrated intravenously via tail vein 3 hours before ischemia.The increasing of AST/ALT level 3 and 6 hours after reperfusion was significantly suppressed by PGJ2. In addition, TUNEL assay revealed that apoptosis after I/R was also suppressed.These data suggested that Nrf2 activation by PGJ2 may bring the beneficial effect in the field of liver surgery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
肝幹細胞誘導による肝虚血耐性獲得の試み
尝试通过诱导肝干细胞获得肝缺血耐受性
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Uchinami, H., Uchinami H, Matsumura Y, 打波 宇, 樋田泰浩, 阿部ゆき]
通讯作者:
阿部ゆき
DOI:
10.1053/j.gastro.2007.02.033
发表时间:
2007-05-01
期刊:
GASTROENTEROLOGY
影响因子:
29.4
作者:
[De Minicis, Samuele, Seki, Ekihiro, Schwabe, Robert F.]
通讯作者:
Schwabe, Robert F.
Acquisition of ischemic tolerance in the liver by induction of liver epithelial cells
通过诱导肝上皮细胞获得肝脏缺血耐受性
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Uchinami, H., Uchinami H, Matsumura Y, 打波 宇, 樋田泰浩, 阿部ゆき, 石川慶大, Abe Y]
通讯作者:
Abe Y
The Forkhead Transcription Factor FoxO1 Regulates Proliferation and Transdifferentiation of Hepatic Stellate Cells
叉头转录因子 FoxO1 调节肝星状细胞的增殖和转分化
DOI:
--
发表时间:
2007
期刊:
Gastroenterology 132
影响因子:
--
作者:
[Adachi, M., Osawa, Y., Uchinami, H., Kitamura, T., Accili, D. and Brenner, D. A.]
通讯作者:
D. A.
An analysis of intrahepatic lymphatic invasion in the patient with intrahepatic cholangiocarcinoma
-
批准号:23591979
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2011
-
负责人:UCHINAMI Hiroshi
-
依托单位:
海外基金